AMH and eosinophilia-myalgia syndrome: Serum CA125 levels were significantly higher in patients with severe EMs compared to the control group (82.35 ± 85.47 versus 14.23 ± 8.04; P < 0.001), while no statistical difference was observed between the two groups in serum AMH levels (3.62 ± 3.20 versus 3.42 ± 1.86; P > 0.05).